File Download
  Patent History
  • Application
    US 12/3294306 2011-11-11
  • Publication
    US 20120121634 2012-05-17
Supplementary

published patent: Soluble Pd-1 Variants, Fusion Constructs, And Uses Thereof

TitleSoluble Pd-1 Variants, Fusion Constructs, And Uses Thereof
Priority Date2011-11-11 US 12/3294306
2010-11-11 US 12/412557P
Inventors
Issue Date2-Nov-2012
Citation
US Published patent application 20120121634. Washington, DC: US Patent and Trademark Office (USPTO), 2012 How to Cite?
AbstractThe Subject Invention Provides Novel Soluble Pd-1 (Spd-1) Proteins, Nucleic Acids, And Fusion Constructs Thereof, For Enhancing Humoral And Cell-Mediated Immunity Of A Subject. Also Provided Are Therapeutic Compositions Comprising The Spd-1 Proteins, Nucleic Acids, And Fusion Constructs Of The Subject Invention. In A Preferred Embodiment, The Therapeutic Composition Is Formulated As A Vaccine Composition. Advantageously, The Spd-1 Proteins, Nucleic Acids, And Therapeutic Compositions Provide Protective Immunity Against Pathogenic Infection Including Hiv Infection. In Additon, The Subject Invention Can Be Used In The Prevention And/Or Treatment Of Tumor Or Cancer.
Persistent Identifierhttp://hdl.handle.net/10722/173778

 

DC FieldValueLanguage
dc.date.accessioned2012-11-02T06:19:22Z-
dc.date.available2012-11-02T06:19:22Z-
dc.date.issued2012-11-02-
dc.identifier.citationUS Published patent application 20120121634. Washington, DC: US Patent and Trademark Office (USPTO), 2012en_HK
dc.identifier.urihttp://hdl.handle.net/10722/173778-
dc.description.abstractThe Subject Invention Provides Novel Soluble Pd-1 (Spd-1) Proteins, Nucleic Acids, And Fusion Constructs Thereof, For Enhancing Humoral And Cell-Mediated Immunity Of A Subject. Also Provided Are Therapeutic Compositions Comprising The Spd-1 Proteins, Nucleic Acids, And Fusion Constructs Of The Subject Invention. In A Preferred Embodiment, The Therapeutic Composition Is Formulated As A Vaccine Composition. Advantageously, The Spd-1 Proteins, Nucleic Acids, And Therapeutic Compositions Provide Protective Immunity Against Pathogenic Infection Including Hiv Infection. In Additon, The Subject Invention Can Be Used In The Prevention And/Or Treatment Of Tumor Or Cancer.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleSoluble Pd-1 Variants, Fusion Constructs, And Uses Thereofen_HK
dc.typePatenten_US
dc.identifier.emailChen, Z=zchenai@hkucc.hku.hk-
dc.identifier.emailZHOU, Jingying=jyzhou@hku.hk-
dc.identifier.authorityChen, Z:rp00243-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorChen, Z-
dc.contributor.inventorZhou, Jingying-
patents.identifier.applicationUS 12/3294306en_HK
patents.description.assigneeUniv Hong Kong [Cn]en_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2012-05-17en_HK
patents.identifier.hkutechidAIDS-2010-00369-1en_HK
patents.date.application2011-11-11en_HK
patents.date.priority2011-11-11 US 12/3294306en_HK
patents.date.priority2010-11-11 US 12/412557Pen_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 20120121634en_HK
patents.relation.familyUS 2012121634 (A1) 2012-05-17en_HK
patents.relation.familyWO 2012062218 (A1) 2012-05-18en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats